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Abstract: Bats are being increasingly recognized as reservoir hosts of highly pathogenic 
and zoonotic emerging viruses (Marburg virus, Nipah virus, Hendra virus, Rabies virus, 
and coronaviruses). While numerous studies have focused on the mentioned highly  
human-pathogenic bat viruses in tropical regions, little is known on similar  
human-pathogenic viruses that may be present in European bats. Although novel viruses 
are being detected, their zoonotic potential remains unclear unless further studies are  
conducted. At present, it is assumed that the risk posed by bats to the general public is rather 
low. In this review, selected viruses detected and isolated in Europe are discussed from our 
point of view in regard to their human-pathogenic potential. All European bat species and 
their roosts are legally protected and some European species are even endangered.  
Nevertheless, the increasing public fear of bats and their viruses is an obstacle to their  
protection. Educating the public regarding bat lyssaviruses might result in reduced threats 
to both the public and the bats. 
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1. Introduction 
The European continent is inhabited by 52 bat species; some are threatened with extinction on the 
population level and are hence protected under the International Union for Conservation of Nature 
(IUCN) Red List of Threatened Species and the Convention on the Conservation of Migratory Species 
of Wild Animals [1,2]. The European bat species that inhabit colder regions use torpor and  
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hibernation. Many bat species migrate over vast distances while others are rather territorial. All bats in 
Europe utilize echolocation to navigate. Contrary to the worldwide efforts in protecting bats, they have 
been increasingly gaining attention as potential reservoir hosts of some of the most virulent  
viruses we know. Various publications reviewed bats globally as carriers and potential reservoir  
hosts of human-pathogenic and zoonotic viruses [3–10], while hardly anything is known about  
human-pathogenicity of European bat viruses apart from lyssaviruses. In this review, we discuss a 
selection of viruses as possible threats posed by European bats to the public from our point of view.  
A summary of viruses that have been detected in European bats is given in Table 1 at the end of the 
manuscript. A more comprehensive and up-to-date list of bat-associated viruses can be found online at 
the Database of Bat-associated Viruses (DBatVir) [11]. 
European bat lyssaviruses (family Rhabdoviridae) are the most important zoonotic bat-borne viruses 
in Europe and have been comprehensively reviewed by Banyard et al. in this special issue on bat  
viruses (Title: Lyssavirus Infections of Bats: Emergence and Zoonotic Threat) [12]. Therefore, we will  
provide a short overview. 
Table 1. Viruses of European Bats. 
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Pipistrellus kuhlii Italy Isolation [19] 
Nairovirus Myotis mystacinus France Metagenomics [18] 
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Rhinolophus hipposideros Slovenia PCR [25] 
Pipistrellus nathusii Ukraine PCR [26] 
Pipistrellus pipistrellus Netherlands PCR [27] 
Eptesicus isabellinus  
Hypsugo savii 
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Table 1. Cont. 
Virus Family Genus Bat Species Origin Detection Refs. 













Myotis myotis  
Myotis nattereri  
Nyctalus noctula  
Pipistrellus pipistrellus 
Plecotus auritus 
Germany PCR [31] 
Betaherpesvirus 
Alphaherpesvirus 
Rousettus aegyptiacus Hungary PCR [15] 











































Rotavirus Myotis mystacinus France Metagenomics [18] 
Retrovirus Gammaretrovirus Eptesicus serotinus France Metagenomics [18] 
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2. Molecular Detection of European Bat Viruses 
The postulates drafted by Jacob Henle and Robert Koch in the late 19th century constitute a 
framework regarding the principles of cause-and-effect in microbiology [55]. Back then, it was 
comparatively straightforward to limit cause-and-effect to four postulates, although viruses had not yet 
been discovered nor was molecular biology developed (Table 1). All of the postulates are hard to fulfill 
for viruses, as they do not grow on nutrient media, but require living cells for replication. When looking 
for viruses on a molecular level, it is necessary to consider that only the first postulate can be 
accomplished. Studies identifying a host-pathogen relationship solely at the molecular level do not 
take into consideration that detection does not equal etiology. Even though polymerase chain reaction 
(PCR) screening and metagenomic studies are indispensable and valuable tools, virologists should stay 
close to the Henle-Koch postulates when assuming a possible virulence of viruses detected in bat hosts. 
2.1. European Bat Coronaviruses 
A plethora of coronaviruses has been detected in bats, mostly belonging to the alpha- and 
betacoronaviruses [11,56]. The genus alphacoronavirus hosts human-pathogenic strains (i.e., Human 
CoV 229E and NL63); however, in this review, we will focus on selected highly human-pathogenic 
betacoronaviruses and their European bat virus relatives [56]. 
From November 2002 until July 2003 the world was confronted with the first pandemic of the new 
millennium, caused by a novel coronavirus (CoV) inducing the Severe Acute Respiratory Syndrome in 
humans (SARS) [57–59]. The pandemic spread from its origin, a wet-market in the Guangdong 
province in China, through 33 countries on five continents resulted in more than 8000 infected humans 
of whom more than 700 eventually died [60,61]. The search for the animal reservoir began, identifying 
masked palm civets and bats as possible sources. Subsequently, a plethora of diverse coronaviruses of 
distinct groups have been detected in various bat species around the world via molecular-biological 
techniques. In 2012, another human-pathogenic coronavirus, called Middle East respiratory syndrome 
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coronavirus (MERS-CoV), began spreading from the Arabian Peninsula, so far resulting in globally 
707 laboratory-confirmed cases of infection with MERS-CoV, including at least 252 deaths [62]. 
Dromedaries and bats are suspected as reservoirs for MERS-CoV [63]. Recent findings support the 
plausibility of dromedaries as reservoir species [64]. 
Although numerous studies in European bats report the presence of SARS-like-CoV and  
MERS-like-CoV sequences [21,24–26,65], no final conclusion can be drawn regarding their zoonotic 
potential. A related virus detected in bats cannot necessarily be considered as zoonotic. A few 
alterations in the SARS-CoV spike protein enabled its binding to the host receptor ACE-2, thus  
SARS-CoV became capable of infecting humans [66]. So far, the SARS-like CoV detected in 
European bats lack these alterations and thus are not predicted to be capable of infecting humans. 
Although virus strains might be similar or related on a nucleic acid level, the distinct function of 
proteins is crucial when determining the host range. Therefore, mere similarity is not sufficient to 
examine the potential of viruses to infect humans or even predict their virulence. It took ten years from 
the emergence of SARS-CoV for the first bat CoV to be isolated from Rhinolophus bats in China, that 
displayed the human ACE-2 receptor, which enabled the virus to infect human cells [67]. These 
findings provide evidence for the reservoir theory. From the European perspective, nevertheless, no 
SARS-like CoV or MERS-like CoV has been isolated from any European bat, nor has any 
transmission of SARS-like CoV or MERS-like CoV to humans been reported. The case of MERS-CoV 
is slightly different, as a sequence of 190 base pairs with 100% identity to MERS-CoV was detected in a 
bat (Taphozous perforates—the species identification performed was not beyond doubt, as it was based 
on exclusion criteria (no Cytochrome b sequence of Taphozous perforates is available in GenBank 
[68])) in Saudi Arabia [8]. This finding initiated a controversy among leading CoV experts, as the 
journal Nature recently reported [69]. They discussed that the complete genome sequence of  
MERS-CoV obtained from the bat should confirm that the virus was indeed identical and not 
coincidentally just a short conserved region of the virus genome. Furthermore, a prevalence study 
might provide insights into the distribution of MERS-CoV in bat populations. Although Taphozous 
perforates are not abundant in Europe, climate change and environmental factors may have an effect 
on the future distribution of this bat species (Figure 1) [70]. The case of MERS-CoV emergence 
impressively demonstrates the necessity of virus discovery and prevalence studies. With the first 
sequence of MERS-CoV that became available, bats were suspected as reservoir hosts, not only because 
MERS-CoV is a SARS-CoV relative, but also because previous bat virus discovery studies had provided 
eligible sequences of bat CoV to GenBank, allowing for correlations with the novel MERS-CoV. 
Recently, a quasi-species of MERS CoVs was recovered from nasal swabs of dromedaries of the 
Kingdom of Saudi Arabia [64]. The MERS CoV consensus genome variants from dromedaries and 
humans are indistinguishable, supporting the plausibility of dromedaries in the role of transmission [64]. 
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Figure 1. Geographical distribution of Taphozous perforates [1]. Visualization: ArcGIS  
Explorer.1:50.000.000 [71] (Map sources: Esri, U.S. Geological Survey (USGS), National 
Oceanic and Atmospheric Administration (NOAA). Sources: Esri, DeLorme, USGS, NPS. 
Spatial data source: International Union for Conservation of Nature (IUCN)). 
 
2.2. European Bat Filoviruses 
In 2002, the first reported outbreak of filovirus, named Lloviu virus (LLOV), in a European bat 
population occurred in France, Spain, and Portugal [29]. Several colonies of Schreiber’s bats 
(Miniopterus schreibersii) suddenly declined due to an unknown disease. LLOV was found in animals 
that showed signs of viral infection, but not in healthy bats co-roosting in the caves (Myotis myotis). 
LLOV is distinctly related to filoviruses found in African bats and was classified in 2013 as type 
species of the novel genus Cuevavirus [56]. Unfortunately, the lack of successful isolation of LLOV 
prohibits the experimental infection of Schreiber’s bats to clarify whether LLOV is the first filovirus 
capable of inducing disease in bats. This would challenge the hypothesis of bats as potential reservoir 
hosts for other filoviruses like Ebola and Marburg virus. Schreiber’s bats are distributed in distinct 
lineages throughout Oceania, Africa, Southern Europe, and South-East Asia (Figure 2) [72]. They are 
thought to transmit and maintain LLOV across different lineages throughout their habitats, although no 
studies are available to prove this hypothesis. 
Consequently, the sole demonstration of a novel filovirus sequence does not provide evidence of a 
possible public health threat. Following the Henle-Koch postulates, the virus should be isolated and 
further characterized to draw conclusions on the evolution of filoviruses in their respective bat host. As 
most filoviruses are described as highly pathogenic for humans, the occurrence of LLOV should be 
carefully monitored by prevalence studies in the highly abundant Miniopterus schreibersii (Figure 2). 
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Figure 2. Geographical distribution of Miniopterus schreibersii [1]. Visualization: ArcGIS  
Explorer.1:50.000.000 [71] (Map sources: Esri, U.S. Geological Survey (USGS), National 
Oceanic and Atmospheric Administration (NOAA). Sources: Esri, DeLorme, USGS, NPS. 
Spatial data source: International Union for Conservation of Nature (IUCN)). 
 
2.3. European Bat Paramyxoviruses 
In 2012, three distinct paramyxoviruses were detected in German bats, two of which were related to 
the proposed genus Jeilongvirus (Myotis mystacinus, Pipistrellus pipistrellus) and one was related to 
the genus Rubulavirus (Nyctalus noctula) [34]. Another study published in the same year described 
another 12 different paramyxoviruses in bats from Germany (Myotis bechsteinii, M. daubentonii,  
M. myotis, and M. mystacinus) and Bulgaria (Myotis alcathoe and M. capaccinii), all of which belong 
to the genus Morbillivirus [35]. 
None of the novel bat paramyxoviruses are closely related to viruses of the highly pathogenic genus 
Henipavirus or other human-pathogenic paramyxoviruses [34,35]. There is no evidence to suggest that 
any of these novel paramyxoviruses are capable of infecting humans. Similar to the case of the LLOV 
filovirus, virus isolates and prevalence studies in both humans and bats could improve knowledge and 
clarify their zoonotic potential. 
2.4. Other Human-Pathogenic Viruses 
Few studies have documented the negative results from PCR testing of European bats for other 
human-pathogenic viruses. For instance following generic PCR screening for flavi-, hanta- and 
influenza-A viruses in 210 European bats in 2011 [73], testing of another 1369 Central European bats 
for influenza-A viruses [74] and testing 42 European bats for hepadnaviruses in 2013 did not lead to 
the detection of any viral nucleic acids [75]. PCR screening of 468 European bats for orthopoxviruses 
has not revealed any known or novel virus sequences [76]. 
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3. European Bat Virus Isolates 
So far, the only virus isolates (beside lyssaviruses) obtained from European bats are one bunyavirus, 
one adenovirus and 22 orthoreoviruses [13,19,36,37]. These represent the only isolates that would 
allow for further characterization and potential clarification of their zoonotic potential. Nevertheless, 
recombinant viruses, constructed on sequence information, are also valuable tools to study prevalence 
and pathogenicity in vitro. 
3.1. European Bat Bunyavirus Isolate 
Toscana virus (TOSV) was isolated from a bat’s brain in 1988, while simultaneously TOSV was 
isolated from sandflies in the laboratory [19]. As TOSV has never been reported in bats afterwards and 
no hemagglutination-inhibiting antibodies has been initially found in the bat, there is a reasonable 
chance that this TOSV isolation may have been a cross-contamination [77]. 
3.2. European Bat Adenovirus Isolate 
Bat adenovirus 2 (Bat AdV-2) was isolated from a bat’s intestine in 2009 [13], and the whole 
genome was obtained and circumstantially analyzed [14,78]. Bat AdV-2 displays a monophyletic 
relationship to the adenoviruses of canids (CAdV). Moreover, open trading frames (ORF) in the Bat 
AdV-2 genome and the CAdV are identical and not present in other members of the mastadenoviruses. The 
closely related canine AdV contribute to the severe kennel cough syndrome in canids and show an 
unusually broad host range [79]. This provides evidence suggesting an ancestral inter-species 
transmission of mastadenoviruses between bats and canids. Like in the case of rabies virus, which is 
prevalent in both bats and terrestrial mammals (e.g., dogs, raccoons, skunks, and foxes) of the 
Americas, a continuing exchange and transmission between bats and canids or other terrestrial animals 
might be possible [80]. There is no evidence of a zoonotic potential of Bat AdV-2. 
3.3. European Bat Reovirus Isolates 
In 2012, three novel orthoreoviruses were isolated from Plecotus auritus and Myotis mystacinus in 
Germany [36]. A subsequent PCR screening obtained identical viral sequences also in other bat 
species: Pipistrellus pipistrellus, Pipistrellus nathusii, Pipistrellus kuhlii, and Nyctalus noctula. At the 
same time, a group in Italy detected further 19 orthoreoviruses in Myotis kuhlii, Rhinolophus 
hyposideros, Tadarida teniotis, and Vespertilio murinus [37]. 
Summing up the data for the reovirus isolates from Germany and Italy, a close relationship was 
revealed to the genus Mammalian Orthoreovirus (MRV), in particular to an orthoreovirus obtained 
from a dog (strain T3/D04) with hemorrhagic enteritis in Italy [36,37,81]. No ancestral relationship 
was assumed here, but rather an opportunistic ―behavior‖ of the novel closely related MRVs, as they 
were detected in various different bat species. Moreover, the newly isolated MRVs are phylogenetically 
related to viruses capable of inducing severe meningitis in humans [82]. Recently, a study published by 
Steyer et al. described the detection of an MRV from a child hospitalized with acute gastroenteritis  
in Slovenia [83]. The causative agent was determined to be an MRV with the highest similarity of 
98.4%–99.0% in the respective segments to a bat MRV (T3/Bat/Germany/342/08) [83]. This might 
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indicate a human-pathogenic potential of strain T3/Bat/Germany/342/08. As the case of SARS-CoV 
has shown that even small changes in the genome are important for determining the host range, this 
has to be determined for the bat MRVs in further studies. Interestingly, no contact was reported  
between the infected child and bats, but contact to a domestic dog was assumed [83]. The isolated  
viruses will allow for a seroprevalence study (cross-reactivity and cross-neutralization with other 
strains) in humans, which shall be initiated to examine the prevalence of specific antibodies to Bat 
MRVs in Germany and Italy (where these viruses have been found) to clarify their zoonotic potential. 
This is especially interesting as Asian bat orthoreoviruses of the genus Pteropine Orthoreovirus have 
already been linked to potentially zoonotic respiratory diseases in humans [84,85]. 
3.4. European Bat Lyssaviruses 
Rhabdoviruses of the genus Lyssavirus that have been detected in Europe are considerably harmful 
and truly zoonotic agents, inevitably causing the death of unvaccinated humans if not treated in time 
before onset of the rabies disease [86]. Even though bat-transmitted lyssaviruses have a fatality rate of 
virtually 100% and are suspected to be transmissible by bat biting and scratching, the reported total 
number of human fatalities in Europe is low (n = 2–5 since 1963) [86–88]. All described hosts of 
European bat lyssaviruses (EBLV-1 and EBLV-2) are synanthropic, hence sharing their habitats with 
humans [87]. EBLV-1 has been predominantly detected in Eptesicus serotinus and E. isabellinus in 
Europe, both living in buildings, roofs, and attics usually in the southern regions of Europe (E. serotinus 
until 55° North, E. isabellinus in southern Portugal—E. isabellinus is a North African population of  
E. serotinus that is controversially but not concludingly discussed as a novel species [1]), and male 
bats are reported to co-roost with multiple bat species [90]. EBLV-1 was also detected in V. murinus, 
M. schreibersii, M. myotis, M. nattereri, R. ferrumequinum, and T. teniotis. Whether these bat species 
constitute accidental hosts infected by spillover from co-roosting E. serotinus species, or whether they 
are additional reservoirs, has not yet been determined [38–41,91]. 
Two human cases described by Johnson et al. were confirmed as infected with EBLV-2, which is 
prevalent in European M. daubentonii and M. dasycneme [40,86]. M. daubentonii is prevalent in  
north-eastern Europe and is frequently found co-roosting with P. pipistrellus and M. nattereri, whereas 
M. dasycneme is found throughout Europe and in the Mediterranean, co-roosting with M. capaccinii. 
So far, none of the co-roosting bats have been reported to carry EBLV-2 [90]. However, spillover 
transmission to other animals (stone-marten, sheep, and cat) was described for EBLV-1 [92–94]. 
Overall, lyssaviruses prevalent in European bats pose a risk to public health, and preventive 
measures have already been implemented by many European countries for decades (e.g., surveillance, 
vaccination plans, and post exposure prophylaxis) [87]. Especially the high-risk occupational groups 
(i.e., bat workers, bat carers in bat bat hospitals) are at increased risk. However, lyssavirus prevalence 
in European bats is very difficult to determine and results are very heterogenic [40]. The lyssavirus 
prevalences are considerably low, but changes of behavior as a result of a lyssavirus infection may be 
more likely to bring bats into contact with humans. However, it is necessary to balance the risk with 
the total number of fatal human cases during the last 35 years (five cases in 590 million people living 
in greater Europe) [87]. Accordingly, the risk is relatively low and would probably fall to zero if 
people were educated appropriately. Direct contact (bites and scratches) with certain bat species might 
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be risky and require post exposure prophylaxis. Only few of the European bat species are known to be 
reservoirs of EBLV-1 and EBLV-2, but all of the European species are endangered or close to 
extinction. Relocation or culling of bat colonies, in spite of being an obvious solution from the 
viewpoint of the general public, increases the risk of lyssavirus exposure and transmission and should 
not be considered [95]. Only education can channel public fear to avoid further threats to the bats and 
the general public. 
4. Spatial Abundance and Biodiversity 
Alexander von Humboldt discovered the latitudinal gradient in species diversity as early as 1799 [96]: 
The richness of species is subject to a global diversity gradient, abating from the species-rich tropics 
toward the higher latitudes [97]. Bats influence this gradient significantly. More than 1100 bat species 
have been described worldwide. Although they are abundant worldwide except for the polar regions, a 
steep diversity gradient is present from the tropics towards the poles [97–100]. Are fewer viruses 
prevalent in European bats because of the lower abundance of species in the more temperate Europe? 
And is the zoonotic risk posed by bats decreased accordingly? 
Only few studies on the biogeography of microorganisms are available. These studies indicate that 
the latitudinal diversity gradient has either no or a top-down effect on microbial diversity [101–105]. 
Two studies hypothesized that the local diversity and dispersal of viruses is very high, though overall, 
the viral diversity is limited on the global scale [106,107]. Therefore, no assumptions can be made 
regarding the viral diversity in species abundant in temperate climates. As the total number of abundant 
species might not be essential, the change in biodiversity might play a role. 
The effect of decline in biodiversity on the emergence of diseases is subject of numerous 
publications [108–114]. Basically, there are arguments in favor of two controversial theories; reduced 
biodiversity could either increase (dilution effect) or decrease the risk of disease transmission. For 
almost half of the zoonotic diseases that have newly emerged by spillover since 1940, a preceding 
change in land-use, agriculture, and wildlife hunting was reported [108]. All of the above-mentioned 
effects contribute to changes in biodiversity and increased contact situations between human and 
animal hosts, also in Europe. Once spillover in novel hosts has occurred, a high density of the novel 
host population eventually facilitates the establishment in the novel niche. Thus, human 
overpopulation and a decreased biodiversity might be mutual factors promoting the establishment of 
emerging infectious diseases. 
In conclusion, the Baas Becking hypothesis from 1932 might still be appropriate: ―Everything is 
everywhere, but the environment selects‖ [115]. 
5. Conclusive Remarks 
Until now, lyssaviruses have been the only proven zoonotic viruses in European bats and may cause 
rabies in humans. However, only few bat species are known to transmit lyssaviruses in Europe, and the 
number of human cases is rather low. Nevertheless, education of the general public should be 
intensified to avoid easily preventable infections. Although viruses with zoonotic potential have been 
detected in European bats, no clear assumption can be made without further studies. Sero-prevalence 
studies should be conducted on the orthoreoviruses isolated from European bats, especially as a closely 
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related virus was detected in a diseased child in Slovenia [83]. Other bat viruses detected by using 
molecular techniques should be isolated (e.g., MERS-like CoV or Bat Bunyavirus) to allow for 
characterization and follow-up sero-prevalence studies. 
In general, bats are special reservoir hosts because of their biological features, long-time co-evolution 
and high diversity of viruses that can be found. Furthermore, there is neither a clearly decreased risk in 
the emergence of zoonotic viruses in temperate climates compared to the tropics nor a decreased risk 
in regions of lower biodiversity. 
In conclusion, many drivers of emergence in the tropics also have validity in Europe. However, 
European bats are endangered species, and some of them are threatened by extinction. Although 
lyssaviruses are prevalent in European bats, and some viruses might have a zoonotic potential, the 
overall hazard for humans is comparably low. Moreover, the protection of bats (and any wildlife) will 
consecutively also protect the general public. 
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